Fetal ultrasound measurements and associations with postnatal outcomes in infancy and childhood : a systematic review of an emerging literature by Alkandari, Farah et al.
Confidential: For Review Only
 
 
 
 
 
 
Fetal ultrasound measurements and associations with post 
natal outcomes in infancy and childhood - A systematic 
review of an emerging literature 
 
 
Journal: Journal of Epidemiology & Community Health 
Manuscript ID: jech-2014-204091.R3 
Article Type: Research report 
Date Submitted by the Author: n/a 
Complete List of Authors: AlKandari, Farah; University of Aberdeen, Child Health 
Ellahi, Awaiss; University of Aberdeen, Child Health 
Aucott, Lorna; University of Aberdeen, Medical Statistics 
Devereux, Graham; University of Aberdeen, Child Health 
Turner, Steve; University of Aberdeen, Child Health 
Keywords: FETAL, CHILD HEALTH, CHRONIC DI 
  
 
 
http://mc.manuscriptcentral.com/jech
Journal of Epidemiology & Community Health
Confidential: For Review Only
 1 
Fetal ultrasound measurements and associations with post natal outcomes in infancy and 
childhood - A systematic review of an emerging literature 
Farah AlKandari
1
, Awaiss Ellahi
1
, Lorna Aucott
2
, Graham Devereux
1
, Steve Turner
1
 
1
Child Health, University of Aberdeen, Aberdeen, UK 
2
Department of Medical Statistics, University of Aberdeen, UK 
 
Contact: Dr Turner, Child Health, Royal Aberdeen Children’s Hospital, Aberdeen, UK, AB25 2ZG.  Tel 
+44 1224 438470, e mail s.w.turner@abdn.ac.uk 
 
Correspondence to: Dr Turner, Child Health, Royal Aberdeen Children’s Hospital, Aberdeen, AB25 
2ZG, UK.  Tel +44 1224 438470. s.w.turner@abdn.ac.uk 
 
Licence for Publication 
 
The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of 
all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis 
to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in JECH and any 
other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our 
licence (http://group.bmj.com/products/journals/instructions-for-authors/licence-forms). 
 
 
Competing Interest: None to declare. 
 
Funding statement: This research received no specific grant from any funding agency in the public, 
commercial or not-for-profit sectors. 
 
Contributorship statement: All authors were involved in conception and design.  FH and AE 
undertook the searches.  ST drafted the initial version of the manuscript and all authors contributed 
to revisions.  ST is the guarantor of this work 
Key words: Chronic disease, Epidemiology, Fetus, Longitudinal studies, Ultrasound 
Word count: 4470
Page 1 of 41
http://mc.manuscriptcentral.com/jech
Journal of Epidemiology & Community Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 2 
ABSTRACT  
Background. Several hypotheses predict that faltering fetal growth is an antecedent for common 
non-communicable diseases.  This is the first systematic review of an emerging literature linking 
antenatal fetal measurements to postnatal outcomes 
Methods. Electronic databases (OVID, EMBASE and Google Scholar) and cohort study web sites were 
searched in July 2014.  Studies were selected which examined associations between antenatal fetal 
ultrasound measurements to post natal outcomes.  Neonatal outcomes, e.g. premature delivery, 
were not included. 
Results. There were 23 papers identified from cohorts in Western countries, including 11 from a 
single cohort.  Four papers reported outcomes in children aged over six years.  Small,  but not large, 
for gestational age (SGA) was associated with adverse outcomes except for one study where 
individuals with  the lightest or heaviest estimated fetal weight risk were at increased risk for autistic 
spectrum disorder. The magnitude of associations was modest, for example each z score reduction 
in fetal size was associated with 10-20% increased risk for delayed development or a 1mmHg 
increase in blood pressure. Associations between decelerating in utero growth and outcomes were 
less consistent since growth acceleration and deceleration were both associated with adverse and 
advantageous outcomes.     
Conclusions.  There is consistency for antenatal SGA and growth deceleration being associated with 
adverse outcomes determined in early childhood.  Accelerating fetal growth was associated with 
both advantageous and disadvantageous outcomes, and this is consistent with the concept of 
predictive adaptive responses where exposure to a post natal environment which was not 
anticipated predisposes the fetus to adverse health.   
Page 2 of 41
http://mc.manuscriptcentral.com/jech
Journal of Epidemiology & Community Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 3 
What this paper adds 
What is already known on this subject.  Poor fetal growth (as evidenced by low birth weight) is 
associated with adverse outcomes in childhood and adulthood.  Hypotheses such as the fetal origins, 
developmental programming and predictive adaptive responses implicate deviations in fetal growth 
in causation of non communicable diseases. 
What this study adds.  Where associations were present, being small for gestational age was 
generally associated with adverse outcomes. There was evidence that both growth deceleration  and 
acceleration were associated with adverse outcomes, and there were inconsistent associations 
between studies. 
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INTRODUCTION 
Historically, before the 1990, the human fetus was considered as inhabiting a privileged 
environment where it was insulated from harm by the materno-placental unit
1
, but this paradigm is 
no longer accepted. Cohort studies with extended follow up of the offspring of mothers exposed to 
starvation during pregnancy, such as during the Dutch Famine
1,2
 and the Leningrad Siege 
3
,  have 
demonstrated how this exposure was associated with both reduced birth weight and increased 
incidence of non-communicable diseases (NCD) or their physiological features
4
. A number of 
mechanisms have been proposed as explanations for associations between reduced fetal growth, as 
evidenced by reduced birth weight, and a broad spectrum of adult non-communicable diseases for 
which there is no cure including cardiovascular disease
5
, type II diabetes
6
, psychiatric diseases
7
, 
chronic renal failure
8
 and polycystic ovarian disease
9
.  These mechanisms include the thrifty 
phenotype
10
, the fetal origins hypothesis 
5
, developmental plasticity
11
 and predictive adaptive 
responses
12
 and collectively fall under the concept of developmental origins of disease
4
(DOHaD). The 
thrifty phenotype and fetal origins hypotheses are focussed on fetal growth failure and predict that 
faltering fetal growth will be associated with adverse outcomes. The developmental plasticity and 
predictive adaptive responses theories would be less specific in predicting outcome but maintain 
that a single individual can achieve a number of phenotypes depending on the developmental milieu 
and that both fetal growth deceleration and acceleration may be beneficial or harmful to the 
individual depending on the postnatal environment. 
 
Understanding the developmental mechanisms associated with faltering fetal growth and non-
communicable diseases will inform antenatal preventative interventions which will ultimately 
improve the health of the population and reduce burden on healthcare resources 
13
.  A major 
challenge to understanding fetal origins of non-communicable diseases in humans is measuring fetal 
well being.  Fetal anthropometry, as evidenced by ultrasound measurement, has been used as an 
index of fetal well being and related to risk for outcomes in childhood.   There is now emerging 
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 5 
literature relating  antenatal fetal measurements to childhood outcomes including asthma, allergy, 
obesity and hypertension and it is possible to determine whether the literature refutes or supports 
previous theoretical work.  The present systematic review was designed to answer the question “are 
there consistent associations between antenatal size (e.g. small for gestational age) and faltering 
fetal growth  and post natal outcomes?” The focus was on postnatal outcomes where DOHaD may 
be important and we set out to determine which of the different developmental theories best fitted 
the summation of the evidence identified.   
 
METHOD 
Search Methodology 
The database search was carried out in July 2014 using OVID and also EMBASE and Google Scholar 
databases.  The following terms were used for the search and were identified after reviewing 
relevant publications already known to the authors (also see online supplement for search strategy 
used): “Child”, “Follow-up/Cohort/Epidemiological/Cross-sectional/Prospective Studies”, “Fetal 
growth/development”, “Infant/Infant New-born” and “Humans”.  Abstracts were reviewed 
independently by two researchers (FA and AE) and studies which potentially related antenatal fetal 
outcomes to postnatal outcomes identified.  Eligible papers had to include fetal anthropometric 
ultrasound measurements representative of overall fetal size (i.e. crown rump length, biparietal 
diameter, head circumference, femur length, abdominal circumference and estimated fetal weight) 
as the predictive variable and postnatal outcomes determined ≥1 week after birth as the outcome.  
Studies which described outcomes of antenatal fetal congenital anomalies, eg echogenic bowel, 
congenital heart disease, cystic lesions in brain, lung and kidney, were not eligible since these fetal 
measurements were not representative of overall fetal size.  Studies which related fetal 
measurements to perinatal outcomes (e.g. prematurity, increased/reduced birth weight and 
complications of delivery) or maternal  exposures during pregnancy (e.g. maternal smoking or 
ambient air quality), were not eligible since our research question was focussed on the relationship 
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between antenatal measurements and post natal outcomes which were or might be pre-clinical 
indices for non-communicable disease.  Three authors (FA, AE and ST) then agreed on the abstracts 
where full papers should be accessed.  Further papers were identified by searching reference lists of 
identified papers and also from the websites for three key cohorts where fetal measurements were 
known to have been linked to post natal outcomes: Generation R 
(http://www.erasmusmc.nl/epi/research/Generation-R/?lang=en), Southampton Women’s Survey 
(http://www.leu.soton.ac.uk/sws/) and “Raine Cohort (http://www.rainestudy.org.au/). Outcomes 
were sought for (i) size for gestational age (including small for gestational age) and (ii) fetal growth 
trajectory (including  growth deceleration).   
Description of fetal measurements.  The variables included were: Crown rump length (CRL), 
biparietal diameter (BPD) and abdominal circumference (AC) were measured in the first trimester 
(i.e. up to 12 weeks gestation).  In the second trimester (i.e. 13 to 27 weeks gestation) and third 
trimester (i.e. 28 weeks and beyond) head circumference (HC), femur length (FL) and BPD and AC 
were measured; estimated fetal weight (EFW) was derived from HC, AC and FL measurements.   
Quality assessment 
Quality assessment of all the included papers was carried out using a standard tool developed for 
use in any public health topic area (http://www.ephpp.ca/Tools.html).  This process provides the 
reader with a global score as to the quality of evidence provided plus each study is rated over six 
domains (selection bias, study design, confounders, blinding, data collection methods and 
withdrawals and drop outs).  Each domain is scored 1-3 and from these scores the global score is 
derived (1=strong study design, 2=moderate and 3=weak).  Each paper was scored independently by 
two of the authors and a final score agreed. 
 
RESULTS  
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The OVID search identified 450 study abstracts, 33 full texts were retrieved and 19 of these papers 
were ultimately included (see figure 1).  The EMBASE and Google scholar searches produced 36 and 
4074 abstracts respectively, none of which yielded additional papers.  A paper which described 
associations between antenatal and postnatal echocardiographic outcomes was not included
14
.  Four 
further papers were identified from previously described cohort web sites.  Of the 23 papers 
included in this review
14-36
, 11 arose from the Generation R cohort, four from Southampton Women 
Survey (SWS), three from the Raine cohort, two from the Study of Eczema and Asthma To Observe 
the influence of Nutrition (SEATON) cohort and three from other studies.  Only four studies 
presented results in children aged more than six years 
16,26-28
.  All studies were from European or 
North American populations.  Table 1 describes which fetal measurements were made in the five 
cohorts whose papers were included.  Table 2 gives an overview of associations between small for 
gestational age and post natal outcome while table 3 describes associations between changing fetal 
size and postnatal outcomes. Table E1 on the on line data supplement presents fuller description of 
the study design and magnitude of the associations reported in individual papers.  For each study, 
outcomes were first related to fetal size for a given gestation and then to fetal growth.  Outcomes 
were categorised into: respiratory, allergy, obesity, neurodevelopmental, autistic spectrum 
disorders, febrile seizures, cardiovascular, renal and bone mineralisation.  One  of the studies 
achieved a strong global rating
15
, 12 received a moderate rating (most failed to gain strong rating by 
not demonstrating how non participation affected the population demographics) and the remainder 
were given a weak rating (most failed to gain moderate rating by not demonstrating whether/how 
confounders such as maternal smoking and socioeconomic status were considered), see online data 
supplement table E2. Of the 6 studies which found no evidence of association between small fetal 
size and post natal outcome, 4 were of poor quality study design 
23,3526
 and 2 of moderate quality 
17,31
.  Among the 4 studies which found no association between changing fetal size and outcomes, 3 
were of moderate quality design 
21,24,31
     and the fourth of poor quality 
32
. 
 
Page 7 of 41
http://mc.manuscriptcentral.com/jech
Journal of Epidemiology & Community Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 8 
Respiratory outcomes 
There were four studies identified including two from the SEATON cohort.  In the SEATON cohort,   
being small for gestational age(SGA) in the first trimester was associated with higher risk for doctor 
confirmed asthma and lower Forced Expiratory Volume in one second (FEV1) at five
15
 and ten years 
of age
16
.  Second trimester SGA  (here BPD was the measurement) was associated with higher 
asthma risk
15
 at five and lower FEV1 and Forced Expiratory Flow at 25-75% of Forced Vital 
Capacity(FEF25-75) at ten years
16
.  Fetal measurements were not associated with bronchodilator 
response at five years, bronchial hyperreactivity at ten years, or exhaled nitric oxide at five or ten 
years.  Growth acceleration between the first and second trimesters was associated with lower 
FEF25-75 at five and ten years but lower asthma risk at ten years compared with persistent high 
growth
15
.  Growth acceleration between the first and second trimesters was also associated with 
lower risk for wheeze at three years of in the SWS
18
; here children were stratified by skin prick 
positivity and increasing HC between 11 and 19 weeks was associated with lower risk for non-atopic 
wheeze.  Increasing AC growth between 19 and 34 weeks was also associated with lower risk for 
atopic wheeze
18
.  In the Generation R Cohort
17
 there were no associations between fetal 
measurements or growth and respiratory outcomes at four years but postnatal weight gain was 
positively associated with risk for symptoms, regardless of antenatal size or growth.     
Allergy outcomes 
There were four papers identified.  In the SEATON study, fetal size for a given gestation was not 
associated with risk for hayfever or eczema at ten years
16
 (results not presented at five years) nor 
with skin prick reactivity five
15
 or ten
16
 years.  When compared to persistent high growth, 
accelerated fetal growth size during first and second trimesters was associated with higher eczema 
risk and decelerating fetal growth  with lower hay fever risk at ten years
16
.  In SWS
18
, increasing AC 
growth between weeks 11 and 19 was also associated with higher risk for atopy but increasing AC 
growth between 19 and 34 weeks gestation was associated with decreased risk for atopy in three-
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year-olds
18
.  In contrast, in the Generation R cohort
17
 increasing AC between the 2
nd
 and 3
rd
 
trimesters was associated with higher risk for eczema at four years.   
Obesity  
Obesity outcomes were reported in five studies, four from Generation R.  In the Generation R 
Cohort, absolute measurements of second and third trimester EFW were not related to fat mass at 
age 6 months (calculated by dual-energy X-ray absorptiometry, DEXA)
20
 but a relative increase in 
EFW z score of >0.67 was associated with higher fat mass.  In a second paper from Generation R, 
SGA for third (but not second) trimester EFW was associated with an increase of borderline 
significance in ultrasound-determined abdominal fat deposits at age two years
21
; the change in EFW 
between second and third trimesters was not associated with abdominal fat measurements
21
.  In the 
third paper, first trimester CRL and second and third trimester FL and EFW were linked to peak 
velocities in height, weight and body mass index (BMI) up to four years of age
22
.  There was no 
association between first trimester CRL and outcomes. There were positive associations between 
second (but not third) trimester EFW and peak weight velocity and FL and peak height velocity.  
Second and third trimester EFW and relative growth between these times were all positively related 
to body mass index at adiposity peak.  In the final paper from the Generation R cohort, first 
trimester size was related to total body fat at a median age of six years and each increase in z score 
in CRL was associated with a 0.3% reduction in total body fat [95% CI 0.03, 0.57] 
36
. In the Project 
Viva cohort
19
, individuals in the highest quartile for EFW had higher BMI z score at three years and 
were at higher risk for obesity (defined as ≥95
th
 centile) when compared to the lowest quartile
19
.  
Compared to individuals in the lowest EFW and birth weight quartiles, those in the highest EFW and 
birth weight quartiles had higher BMI at three years of age.  There were no associations between 
EFW and birth weight and skinfold thickness at three years of age, i.e. an index of adiposity
19
.   
Plasma lipid outcomes 
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 10
In a recent paper from the Generation R cohort
36
 each z score increase in CRL was linked to a mean 
reduction of 0.05 mmol/L cholesterol [95% CI 0, 0.10] in six year olds.  There was also a trend which 
approached significance for an inverse relationship between CRL and plasma low density lipoprotein 
but no association was apparent for triglycerides. 
Neurodevelopment  
There were three studies to consider neurodevelopment.  One Generation R Cohort paper described 
associations between SGA for second and third trimester AC, EFW and ratio of AC:HC (but not HC per 
se) and higher risk for being in the lowest tertile for Touwen’s Neurodevelopmental Examination at 9 
to 15 weeks of age
24
.  A second Generation R cohort publication related SGAfetal HC measurements 
in early, mid and late pregnancy to increased risk for delayed social development at twelve months, 
SGA HC in late pregnancy was also associated with increased risk for delays in self help and fine 
motor skills.  Reduced relative size  in HC between early and mid pregnancy (i.e. IUGR) was 
associated with higher risk for delayed fine motor development and SGA HC growth in later 
pregnancy with higher risk for delayed self-help abilities, gross and fine motor and language 
development at 12 months
25
.  A case-control study from the Raine cohort related FL and HC at 18 
weeks and HC at delivery to Specific Language Impairment
23
 and there were no differences in fetal 
measurements between the 30 case and 30 controls.  The prevalence of microcephaly (i.e. HC at 
birth <-1.67 z score) was higher among cases (40%) compared to controls (10%)
23
.   
Autistic spectrum disorders (ASD) 
There were three case-control studies.  A study from the Raine cohort found no difference in head 
circumference at 18 weeks gestation and birth between 14 cases with ASD and 56 matched 
control
27
.  A study from America 
26
 also found no difference in second trimester BPD, AC and FL 
between 45 cases and 222 controls.  In a post hoc analysis, cases were subcategorised as multiplex 
autism (i.e. autism occurring in association with schizophrenic symptoms, n=8) or simplex autism 
(n=33); multiplex autism was associated with SGA AC compared with simplex autism and also with 
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controls
26
.  A third study from Sweden compared second trimester EFW between 4283 children with 
ASD and 36,588 controls
28
.  ASD risk was higher for the smallest and largest EFW, ie both small and 
large for gestational age.  When individuals were subcategorised as ASD with or without intellectual 
disability, the associations with EFW were similar.  
Febrile seizures 
The Generation R cohort team related SGA second and third trimester fetal transverse cerebellar 
diameter [TCD] to risk for febrile seizures by two years of age
29
.  There were 67 cases among the 
3372 children studied.  Individuals in the lowest tertile of third trimester EFW, AC and FL (but not 
HC) measurements were also at higher risk for febrile seizures compared to the highest tertile.  
Cases had EFW similar to controls at 16 weeks gestation but by 34 weeks gestation, EFW was -0.4 z 
scores relatively lower for cases suggesting IUGR rather than SGA was important.   
Cardiovascular Outcomes  
Four reports considered cardiovascular outcomes.  A study from the Raine Cohort related FL, AC and 
HC measured between 18 and 38 weeks gestation to systolic blood pressure (SBP) at age six years in 
707 individuals
30
 and observed an inverse association between  FL and SBP.  A similar finding was 
seem in the Generation R cohort where SGA  FL at 30 (but not 20) weeks gestation was associated 
with increased SBP at age two years
31
.  A second Generation R study reported a mean reduction in 
diastolic (but not systolic) blood pressure at six years of age of 0.43 mmHg [0.01, 0.84] for each z 
score increase in first trimester CRL but this association was not significant when the child’s weight 
was considered
36
.  In the project Viva cohort 
19
, relative to individuals in the lowest quartiles for both 
EFW and birth weight, elevated SBP at three years was present among those who were (i) in the 
highest EFW quartile and second lowest birth weight quartile (ii) in the second lowest quartile for 
both and (iii) in the second lowest EFW quartile and second highest birth weight quartile. 
Renal Outcomes 
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In the one paper identified, third (but not second) trimester HC and AC were positively associated 
with kidney volume at the age of 2 years
32
.  There was no association between growth in HC and AC 
between second and third trimesters and kidney volume
32
.   
Bone mineralisation 
There were four studies identified.  In the first of three studies from the SWS, FL measurements at 
19 and 34 weeks and growth between these gestations were positively associated with bone mineral 
content and skeletal size (expressed as bone area) in four year olds
33
; bone outcomes were 
determined by whole-body DEXA scan.  There were less convincing positive associations between AC 
and bone mineralisation.  Femoral neck section modulus, an index of bending strength and relevant 
to fractures in the elderly, was determined in 493 six year olds in SWS and increasing FL growth 
between 19 and 34 weeks (and to a lesser degree between 11 and 19 weeks) was positively 
associated with this outcome 
37
.  In the second study, growth in FL and AC between the 11
th
 and 19
th
 
weeks of pregnancy was positively associated with bone area and bone mineral content at birth and 
four years of age
34
.  In the Generation R Study
35
, second and third trimester EFW were positively 
associated with bone mineral density (BMD) and content (BMC) in six month olds; some associations 
were only present for either lumbar spine only or total body BMD and BMC.  Change in EFW 
between 20 and 30 weeks, but not between 30 weeks and term, were also positively associated with 
BMD for TB.  
 
DISCUSSION 
This is the first systematic review of the literature relating antenatal fetal size and growth to 
postnatal outcomes.  We considered a broad spectrum of post natal outcomes since some organs 
pass through important developmental stages at the same gestation and an antenatal exposure at a 
given time might affect more than one organ.  Equally, different organs develop at different 
gestations and serial fetal ultrasound measurements can give insight into the developmental origins 
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of different health outcomes.  The first main finding was that when associations were present, it was 
small for a given gestational age (and not large) that was linked to adverse outcomes with the 
exception of one study which found higher risk for autistic spectrum disorder among the smallest 
and largest second trimester fetuses
28
.  The second notable finding was that growth deceleration 
was associated with some unfavourable outcomes although there were some inconsistencies 
between studies.  The final important finding was that in utero growth acceleration was associated 
with adverse and beneficial outcomes (e.g. higher risk for asthma, obesity and atopy but also higher 
bone mineral density, table 3).  The magnitude of associations between fetal measurements and 
outcomes, when present, was generally modest for an individual, but these associations may be 
relevant to public health where small changes in risk may lead to large absolute number of 
individuals with incurable outcomes such as coronary artery disease, type II diabetes and asthma.  
Our conclusions are based on studies from Europe, North America and Australia this adds a 
limitation that the results may not be generalisable to other populations where different genetic, 
environmental and socioeconomic influences may be present.  We point out that causation cannot 
be implied from the associations we describe from the observational studies identified. The cohort 
members are still young, some of the associations described may resolve over time and it will be 
many years before follow up will be able to link fetal measurements to outcomes such as 
cardiovascular disease
5
 and type II diabetes
6
.   
 
Most studies found small for gestational age to be associated with a higher risk for “adverse” 
outcomes, and included birth weight and postnatal measurements in the analyses indicating that the 
“adverse outcomes” were not simply small fetuses becoming small infants and children.  Inclusion of 
birth weight as a confounder does determine whether antenatal or neonatal measurement is more 
relevant to the outcome.  Inclusion of birth weight might be a case of over adjustment since this 
birth weight is on any causal pathway between fetal measurements and post natal outcome and 
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therefore unlikely to be a confounder.  Moreover adjustment for birth weight may inadvertently 
adjust for a mediator/exposure which affects fetal growth in later pregnancy.  
 
Developmental pauses at critical stages of development might explain these associations, for 
example the association between small for gestation and lower lung function was apparent from the 
first trimester 
16
 suggesting a problem in development occurring in very early pregnancy whereas 
associations with higher blood pressure were more apparent at 30 weeks gestation than at 20 weeks 
30,31
.  During the embryonic and fetal periods, organs develop according to different timetables; for 
example in the lungs airway division occurs by 16 weeks gestation
38
 whereas in the kidneys, 
glomerulogenesis occurs between 7 and 35 weeks gestation
39
.  In this context, a transient exposure 
before 16 weeks might lead to a life-long aberration in airway function but not adversely affect renal 
function and the fetus will achieve a normal/near normal birth weight.  
There was some consistency between studies for associations between change in fetal size and 
outcomes, for example (i) accelerated growth during early pregnancy associated with higher risk for 
eczema
16
 and atopy
18
 (ii) accelerated growth during later pregnancy associated with increased fat 
mass
20
, body mass index
22
 and bone mineral density
33,35
.  There were also some apparent 
inconsistent associations between studies, for example (i) accelerated growth during late pregnancy 
and higher risk for eczema
17
 but also lower risk for atopy
18
 and hayfever
16
 (ii) accelerating 
19
 and 
decelerating
19
 growth during later pregnancy associated with higher systolic blood pressure or not at 
all
31
.  These different outcomes may reflect differences in ages at postnatal assessment, different 
methodologies used to measure outcomes and differences between study populations.  These 
different outcomes might also reflect genuine differences in determinants of antenatal growth in 
different populations. 
The “fetal origins” hypothesis proposed that faltering growth during mid gestation was associated 
with higher risk for cardiovascular disease and we found evidence of faltering fetal growth being 
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associated with higher blood pressure (table 3) and also with other unfavourable outcomes including 
lower lung function and developmental delay.  We also found evidence for increasing growth during 
early and late pregnancy being associated with higher risk for adverse outcomes in young children 
including lower lung function, increased asthma and adiposity (table 3).  Associations between 
relative acceleration and deceleration in  growth and “advantageous” and “disadvantageous” 
outcomes are not consistent with the fetal origins hypothesis but are in keeping with the predictive 
adaptive response hypothesis
12
 where fetal growth anticipates the post natal environment, and 
inappropriate (positive or negative) fetal growth may be disadvantageous.  The relationship between 
fetal growth and post natal outcomes may be modified by post natal growth trajectories, as was 
found in some studies included in this review
17
 
20
.  Large cohorts with detailed follow up and 
advanced statistical approaches are required to understand the complex relationship between 
antenatal growth and postnatal morbidity.   
There are a number of limitations to this review. First, there was considerable heterogeneity 
between study designs and meta analysis of data was not possible, furthermore outcomes measured 
within studies sometimes varied as the study participant became older, eg obesity and 
neurodevelopmental outcomes, and this limits direct comparison of results from the same cohort.  
Second, gestational age certainty is crucial to the accurate interpretation of fetal measurements
40
 
and there is inevitable inaccuracy regardless of whether date of last menstrual period or first 
trimester fetal measurement is used (or combination of these), however this inaccuracy is not likely 
to alter the direction of any associations between fetal size and outcome within a population but is 
likely to reduce the true magnitude of any  associations.  A third factor to consider is that fetal 
measurements may not be an accurate index of fetal wellbeing, although the evidence from this 
review does support the role of fetal measurements as a surrogate for fetal wellbeing. Statistical 
points to note are that false positive results with borderline p values may have arisen due to 
multiple testing within studies and also due to post hoc analyses.  Fourth, our quality control found 
that only one study had strong design; although blinding and data collection methods were strong, 
Page 15 of 41
http://mc.manuscriptcentral.com/jech
Journal of Epidemiology & Community Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 16
details were missing for how representative cohorts were of the general population, how 
incomplete participation at post natal follow up might bias the population studies and the 
confounders adjusted for.  Perhaps most importantly there were no intervention studies included 
and causation can only be determined from such studies and not from observational studies such as 
we describe here.  Nutritional interventions aimed preventing impaired fetal growth, but where 
antenatal fetal measurements were not made, have met with limited success 
41
 and might offer a 
mechanism to alter antenatal growth.    
In conclusion, this review of the literature has identified evidence that small fetal size and changes in 
fetal growth trajectory may be important to post natal outcomes.  These associations do not prove 
causation but do suggest that antenatal interventions might be one option of preventing non-
communicable diseases in adulthood.  The associations reported here require replication in non-
Western populations to confirm world-wide generalizability.  Future research might look at 
intervention strategies aimed at preventing small for gestational age and growth failure but avoid 
stimulating fetal growth acceleration since this may lead to unwanted outcomes (table 2). 
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Table 1.  Details of the five cohorts which have linked antenatal fetal measurements to post natal outcomes.   
 
Cohort Country  Years of 
recruitment 
Number 
recruited 
Fetal measurements 
available 
Rationale for 
recruiting cohort 
Inclusion and 
exclusion criteria 
Generation R
42
 Netherland 2002-2006 9778 mothers  
and details 
from 5125 
offspring 
including 
more detailed 
assessment in 
≤1232  
T1: CRL (used for 
dating) 
T2+3: BPD, HC, AC FL, 
EFW, transverse 
cerebellar diameter 
To identify early 
environmental and 
genetic causes of 
normal and abnormal 
growth, development 
and health from fetal 
life until young 
adulthood 
Delivery date April 
2002-January 2006. 
Recruitment any 
time during 
pregnancy (ideally 
<18 weeks).  Living 
within Rotterdam 
area. No exclusion 
criteria stated. 
Southampton Women’s 
Survey
43
 
UK 1998-2002 12579 women 
(75% of all 
women 
approached)  
of whom 2567 
became 
pregnant and 
delivered live 
born infant by 
2005 
Weeks 11, 19 and 34: 
FL, AC 
To learn more about 
the dietary and 
lifestyle factors that 
influence the health 
of women and their 
children 
Women aged 20-34 
years recruited 
between 1998 and 
2002.  Infant born 
<37 weeks gestation 
were excluded. 
Raine cohort
44
 
 
Australia 1989-1991 2876 Weeks 18, 24, 28, 34 
and 38 (in 1415*): AC, 
HC and FL 
To determine 
whether use of 
multiple ultrasound 
assessments 
improved pregnancy 
Mothers 16-20 
weeks pregnant. 
Fluent in English and 
expected to deliver 
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outcomes in the recruiting 
hospital 
SEATON study
45
 
 
UK 1997-1999 2000 mothers 
(of 2690 
invited to take 
part) who 
delivered 
1924 live born 
singleton 
infants 
T1 CRL, T2 BPD and FL 
no antenatal T3 
measurements 
To detect 
associations between 
maternal diet during 
pregnancy and 
childhood asthma 
and eczema 
Mother 10-12 weeks 
pregnant.  Other 
exclusion and 
inclusion criteria not 
described 
Project Viva
46
 
 
http://dacp.org/viva/index.html 
USA 1999-2002 2671 mothers 
(64% of 
eligible) of 
whom scan 
details were 
used in 772 
and of these 
438 were 
followed up at 
3 yrs 
T2 (18 weeks) BPD, FL, 
AC and EFW 
To find ways to 
improve the health of 
mothers and their 
children by looking at 
the effects of 
mother's diet as well 
as other factors 
during pregnancy and 
after birth 
Mothers recruited 
after initial clinical 
prenatal visit (≤22 
weeks gestation).  
Exclusion criteria 
included multiple 
pregnancy, not 
fluent in English,  
 
T1, 2 and 3 = first, second and third trimesters.  CRL=crown rump length, BPD=biparietal diameter, HC=head circumference, FL=femur length, AC=abdominal 
circumference, EFW=estimated fetal weight (derived from HC, FL and AC).*The Raine cohort was designed to determine whether regular antenatal 
ultrasounds were associated with higher risk of harm to the fetus, mothers were randomised to have either one or five assessments. 
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Table 2.  Summary of associations between being small for gestational age in the first, second and third trimester and outcomes in post natal life.  SWS=Southampton 
Women’s Study, CRL=Crown Rump Length, BPD=BiParietal Diameter, SGA=Small for Gestational Age, EFW=Estimated Fetal Weight, FL=Femur Length, AC=Abdominal 
Circumference, HC=Head Circumference. 
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 Associations with being small for gestational age 
First trimester 
(approximately 10 weeks) 
Second trimester 
(approximately 20 weeks) 
Third trimester 
(approximately 30 weeks) Outcome Cohort 
Respiratory SEATON
15,16
 Higher risk for asthma at 10 yrs 
(CRL) 
Lower lung function at 10 yrs (CRL) 
Higher risk for asthma at 10 yrs 
(BPD) 
Lower lung function at 10 yrs 
(BPD) 
Scan not done 
SWS
18
 Outcomes with SGA not reported 
Generation R
17
 No association with symptoms at 
4yrs 
Outcomes with SGA not reported 
Allergy SEATON
15,16
 No associations apparent between SGA and eczema, hayfever, skin prick reactivity or exhaled nitric oxide 
SWS
18
 Outcomes with SGA not reported 
Generation R
17
 Outcomes with SGA not reported 
Obesity Generation R
20-22
 Not associated with peak growth 
velocities (PGV) 
No relationship with EFW and fat 
mass at 6mo or abdominal fat 
mass (AFM) at 2 yrs.  EFW 
associated with lowerweight PGV 
and body mass index at adiposity 
peak.  FL inversely associated 
with height PGV. 
No relationship with EFW and 
fat mass at 6mo but borderline 
association with AFM at 2 yrs  
and body mass index at 
adiposity peak 
Project Viva
19
 Scan not done Reduced EFW associated with 
lower body mass index and 
obesity at 3 yrs 
Scan not done 
Neurodevelopment Generation R
24,25
 Higher risk for delayed fine motor 
development at 12 mo (HC) 
SGA AC, EFW and AC:HC (not HC) 
and neuromotor developmental 
delay at 9-15 weeks.  SGAHC 
associated with delayed fine 
motor development at 12 mo 
SGA AC, EFW and AC:HC (not 
HC) and neuromotor 
developmental delay at 9-15 
weeks. SGA HC associated with 
global developmental delays at 
12 mo  
Raine
23
 Scan not done No association with specific 
language impairment at 10yrs 
 
Association not reported 
Autism Raine
27
 Scan not done No association with HC and Association not reported 
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autism at 16 yrs 
Hobbs et al
26
 Scan not done No association with BPD, AC or FL 
and autism (mean age 7 years) 
Scan not done 
Abel  et al 
28
 Scan not done Group with lowest (and also 
highest) EFW at highest risk for 
autism by 17 yrs 
Scan not done 
Febrile convulsion Generation R
29
 Association not reported SGA trans cerebellar diameter 
associated with higher risk 
SGA for  trans cerebellar 
diameter, EFW, AC and FL (not 
HC) associated with higher risk 
Blood pressure Raine
30
 Scan not done SGA for  FL (not AC or HC) at 24 
weeks (not 18) associated with 
higher systolic blood pressure 
(SBP) at 6 yrs 
SGA for FL  (not AC or HC) 
throughout associated with 
highersystolic blood pressure at 
6 yrs 
Generation R
31
 Association not reported No association between FL, AC, 
HC or EFW and SBP at 2 yrs 
SGAFL associated with higher 
SBP at 2 yrs 
Project Viva
19
 Scan not done No association between EFW and 
SBP at 3 yrs 
Scan not done 
Renal Generation R
32
 Association not reported No association between HC and 
AC and kidney volume at 2 yrs 
No association between HC and 
AC and kidney volume at 2 yrs 
Bone mineralisation SWS
33,34
 Outcomes with SGA not reported 
Generation R
35
 Association not reported SGA for EFW associated with 
lower bone mineral density and 
content at 6 mo 
SGA for  EFW associated with 
lower bone mineral density and 
content at 6 mo 
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 Table 3.  Summary of adverse outcomes associated with increasing or decreasing growth in fetal measurements during the first or second half of 
pregnancy. *In this paper growth acceleration was linked to reduced risk for hayfever but growth failure not linked to increased risk for hayfever.   
CRL=Crown Rump Length, BPD=Biparietal Diameter, AC=Abdominal Circumference, EFW=Estimated Fetal Weight, HC=Head Circumference 
 
 
 
Growth before 20 weeks gestation 
(fetal outcome measured) 
Antenatal growth after 20 weeks gestation 
(fetal outcome measured) 
 
Accelerating growth 
 
 
 
 
Lower spirometry at five
15
 and ten years
16
(CRL and BPD) 
Higher asthma risk at ten years
16
(CRL and BPD) 
 
Higher eczema risk at ten years
16
(CRL and BPD) 
Higher atopy at three years
18
 (AC) 
Higher non atopic wheeze at three years
18
 (HC) 
 
 
 
Lower spirometry at ten years
16
 (BPD and birth weight) 
Higher asthma risk  at ten years
16
 (BPD and birth weight) 
Lower hayfever risk at ten years
16
 (BPD and birth weight)* 
Higher eczema risk at four years
17
 (AC) 
Higher fat mass at six months
20
 (EFW) 
Higher body mass index at adiposity peak
22
 (EFW) 
  
 
Decelerating growth 
 
 
 
 
 
 
 
 
 
Lower spirometry (FVC) at ten years
16
(CRL and BPD) 
Lower risk for hayfever at ten years
16
(CRL and BPD) 
Higher risk for delay in fine motor development at 12months
25
 (HC) 
Lower bone mineral content at birth and four years
34
(FL and AC) 
Lower femoral neck section modulus (FL) 
37
 
 
Higher risk for several developmental outcomes
25
 (HC) 
Higher risk for febrile convulsions 
29
 (EFW) 
Lower systolic blood pressure at three
19
 years (FL) 
Lower bone mineral density at six months
35
 (EFW) 
Lower bone mineral content at four years
33
 (FL)  
Higher systolic blood pressure at three
19
 and six
30
 years (FL) 
Higherrisk for atopy at three years
18
 (AC) 
Higher risk for  atopic wheeze at three years
18
 (AC) 
Lower femoral neck section modulus (FL) 
37
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FIGURE LEGEND 
 
Figure 1.  Quorum diagram showing how the papers included in this review were identified 
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Fetal ultrasound measurements and associations with non-communicable diseases in childhood - A systematic review of an emerging literature 
Farah AlKandari, Awaiss Ellahi, Lorna Aucott, Graham Devereux, Steve Turner 
 
On line data supplement 
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Table E1.  A summary of the findings of the papers included in this review.  95% confidence intervals are presented in square brackets. 
Study Outcome Cohort name and 
inclusion/exclusion 
criteria 
Sample size, age 
when outcome 
measured  
Outcomes for size for a given 
gestation  
Outcomes for change in fetal 
measurements 
Associations between fetal 
size, maternal alpha-
tocopherol and childhood 
asthma P1P 
 
 
 
 
 
Respiratory and 
allergy 
SEATON 578 five year olds  Inverse association between CRL 
(4%[0,9]  risk reduction per mm) 
and BPD (12%[3, 20] risk reduction 
per mm) and asthma risk at five 
years.  Positive association CRL and 
FEVR1R at five years (increase 4mls 
[1,7] per mm). 
Change from “small” to “large” between 
1PstP and 2PndP trimester associated with 
reduced FEVR1R (73ml [19, 127]) and FEFR25-75 
R(-0.12 l/s [0.003, 0.25]) at five years 
compared to persistently “large” group). 
First and second trimester 
fetal size and asthma 
outcomes at age ten years P2P 
SEATON 449 ten year olds Inverse association between CRL 
and asthma risk at ten years (6% [1, 
11] risk reduction per mm).  
Positive association between CRL 
(increase 6ml [0, 11] per mm) and 
BPD (increase 21ml [9, 33] per mm) 
and FEVR1R at ten years. 
Change from “small” to “large” between 
1PstP and 2PndP trimester associated with 
reduced FEFR25-75 R(-0.21 l/s [0, 0.43] ) and 
increase risk for symptomatic asthma (OR 
5.1 [1.4, 19.2]) and eczema (OR 2.5 [1.2, 
5.3]) at ten years.  Converse change 
associated with reduced FVC (116mls [7, 
225]) and reduced risk for hayfever (OR 
0.10 [0.01, 0.82]). 
Patterns of fetal and infant 
growth are related to atopy 
and wheezing disorders at 
age 3 years P3P 
SWS 1184 three year 
olds 
Associations with absolute size not 
reported 
Increased BPD between 11 and 19 weeks 
associated with reduced non-atopic 
wheeze (10% reduced risk for each z score 
increase).  Increased AC between 19 and 
34 weeks associated with reduced risk for 
atopic wheeze and atopy (20% [0, 35] 
reduction in risk for both outcomes for 
each z score increase CI [0, 35] and [6, 31] 
respectively).  Increased AC growth 
between 11 and 19 weeks associated with 
increased risk for atopy (risk increased by 
46% [11, 93] for each z score increase)  
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Fetal and infant growth and 
asthma symptoms in 
preschool children: the 
Generation R Study P4P 
Generation R 5125 four year 
olds 
No associations between absolute 
fetal measurements and symptoms 
identified.   
No associations between change in fetal 
measurements and respiratory symptoms 
identified.  Each z score increase in AC 
between 20 and 30 weeks associated with 
5% [1,10] increased risk for eczema. 
Fetal and postnatal growth 
and body composition at 6 
months of age P5P 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obesity 
 
 
Generation R 252 six month old 
infants 
No associations between fetal 
measurements  and outcome 
detected 
Increased EFW between 20 and 30 weeks 
associated with ~1% increase in fat mass at 
six months 
Growth in foetal life and 
infancy is associated with 
abdominal adiposity at the 
age of 2 years: the 
Generation R studyP6P 
Generation R 481 two year olds Reduced EFW at 30 weeks 
associated with increased 
abdominal fat deposition at two 
years of age (each z score reduced 
EFW associated with 3.7% [0.1, 7.2] 
increase in preperitoneal fat area) 
No associations between change in fetal 
measurements  and outcome detected 
Fetal and infant growth and 
the risk of obesity during 
early childhood: the 
Generation R StudyP7P 
Generation R 6267 children 
where data 
collected in first 
four years was 
analysed 
Second trimester EFW positively 
associated with peak weight 
velocity (PWV, 12.02 kg/year for 
lowest EFW quintile and 12.16 for 
highest quintile, p<0.05).  Second 
trimester FL positively associated 
with peak height velocity (PHV, for 
highest quintile for FL 49.28 
cm/year compared to 48.89 for the 
shortest FL quintile, p<0.05.  
Increase in EFW between second and third 
trimester associated with increased body 
mass index at adiposity peak (17.68 and 
17.52 kg/mP2P for the groups in the highest 
and lowest quartiles for EFW growth 
respectively) 
First trimester fetal growth 
restriction and 
cardiovascular risk factors 
in school age children: 
population based cohort 
studyP8P 
Generation R 1184 children, 
median age 6.0 
years  
Each increase in first trimester CRL 
z score was associated with a mean 
reduction in total fat mass of 0.3% 
[0.03, 0.57]. This association 
became non significant when the 
child’s current weight was 
considered. 
 
Associations with change in size not 
reported 
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Second trimester estimated 
fetal weight and fetal 
weight gain predict 
childhood obesityP9P 
Project Viva 438 three year 
olds 
Highest EFW quartile at 16 weeks 
had increased BMI z score at three 
years compared to lowest EFW 
quartile (mean 0.34 [0.07, 0.61] z 
score) 
Associations with change in size not 
reported 
Fetal head circumference 
growth in children with 
specific language 
impairmentP10P 
 
 
 
 
 
 
Neurodevelopmental 
outcomes 
Raine 30 cases, 30 
controls aged ≤10 
years 
No association between BPD and 
risk for outcome 
Associations with change in size not 
reported 
Fetal programming of infant 
neuromotor development: 
the generation R study P11P 
Generation R 2965 infants aged 
9-15 weeks 
Reduced AC and EFW associated 
with increased risk for being in 
tertile with “poorest” neuromotor 
outcome (11% [3, 18] increased risk 
for each z score reduction in 
growth) 
No association between change in fetal 
measurements and risk for outcome 
Fetal growth from mid- to 
late pregnancy is associated 
with infant development: 
the Generation R StudyP12P 
Generation R >3045 12 month 
olds 
Reduced HC after 25 weeks 
gestation was associated with 
increased risk for delayed social 
development (18% [7, 23] increase 
risk per z score)  
Reduced HC growth early-mid pregnancy 
associated with increased risk for delayed 
fine motor development (15% [2, 27] 
increased risk per z score reduction).  
Reduced HC growth from mid-late 
pregnancy associated with increased risk 
for delay in the following domains: social, 
self-help and fine motor.  Risk for overall 
developmental delay increased l 15% [-13, 
+36] per z score reduction in HC and 35% 
[13, 51] per z score reduction in EFW.   
Brief report: a preliminary 
study of fetal head 
circumference growth in 
autism spectrum disorderP13P 
 
 
 
 
Autistic spectrum 
disorders (ASD) 
Raine 14 cases and 56 
controls in a 
population aged 
up to 16 years 
No association between second 
trimester HC and risk for ASD 
Associations with change in size not 
reported 
A retrospective fetal 
ultrasound study of brain 
size in autismP14P 
No cohort 45 cases 222 
controls, mean 
age 7 years 
No association between second 
trimester BPD, AC or FL and risk for 
ASD 
Associations with change in size not 
reported 
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Deviance in fetal growth 
and risk of autism spectrum 
disorderP15P 
No cohort 4283 cases and 
36588 controls in 
a population aged 
0-17 years 
Highest risk for individuals EFW <-2 
or >+2 z scores in second trimester 
(increased risk 70% [44, 101] and 
49% [46, 76] respectively) 
Associations with change in size not 
reported 
Fetal growth retardation 
and risk of febrile seizuresP16P 
Febrile convulsions Generation R 3372 (including 67 
with febrile 
seizure) followed 
up to two years of 
age 
Small transverse cerebellar 
diameter (ie lowest tertile) in 
second and third trimester 
associated with increased risk (OR 
2.9 [1.3, 6.3] for second trimester 
measurement when compared to 
highest tertile).  No association with 
HC.  Small third trimester EFW, AC, 
BPD and FL associated with similar 
magnitude of increased relative 
risk.  
Febrile seizures associated with reduced 
EFW after 16 weeks (-0.4 z score [CI not 
presented] ireduction in EFW between 16 
and 34 weeks for cases compared to 
controls). 
Prenatal ultrasound 
biometry related to 
subsequent blood pressure 
in childhoodP17P 
 
 
 
 
 
 
 
 
 
 
Blood pressure 
 
 
Raine 707 six year olds Inverse association between FL 
between 24 and 38 weeks and 
systolic blood pressure (SBP, each z 
score increase associated with 
mean reduction of 1-2mmHg) 
Each z score increase in FL growth 
between 18 and 38 weeks was associated 
with a 0.7mmHg (standard error 0.5) 
reduction in SBP 
Second trimester estimated 
fetal weight and fetal 
weight gain predict 
childhood obesityP9P 
Project Viva 438 three year 
olds 
No association between  absolute 
second trimester size and systolic 
blood pressure 
 
 
 
 
 
 
Compared to those in the lowest quartile 
for second trimester EFW and birth weight, 
there were reductions in the following 
groups growth deceleration (highest to 
second lowest quartile, 5.5 mmHg [1.1, 
10.0] ), growth acceleration (second lowest 
to second highest quartile, 4.6mmHg [0.1, 
9.0]) and remaining in the second lowest 
tertile (5.0 [0.3, 9.7] 
Fetal and postnatal growth 
and blood pressure at the 
age of 2 years. The 
Generation R 566 two year olds Association between increased FL 
at 30 weeks (but not 20 weeks) and 
reduced SBP at two years (mean 
No association between SBP at two years 
and change in FL between 20 and 30 
weeks gestation.  Each z score increase in 
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Generation R StudyP18P reduction 1.2 mmHg [0.3, 2.1] per 
increased in z score).  No 
association with HC, AC or EFW. 
weight between 20 weeks and 2 years 
associated with increased SBP (mean 
increase 0.7 mmHg [0.01, 1.3]).   Each z 
score increase in length between 30 weeks 
gestation and 2 years associate with 
increased SBP (mean increase 1.0[0.3, 1.7] 
mmHg) 
First trimester fetal growth 
restriction and 
cardiovascular risk factors 
in school age children: 
population based cohort 
studyP8P 
Generation R 1184 children, 
median age 6.0 
years  
Each increase in first trimester CRL 
z score was associated with a mean 
reduction in diastolic BP of 0.43 mm 
Hg [0.01, 0.84]. This association 
became non significant when the 
child’s current weight was 
considered. 
Associations with change in size not 
reported 
First trimester fetal growth 
restriction and 
cardiovascular risk factors 
in school age children: 
population based cohort 
studyP8P 
Metabolic outcomes 
 
 
Generation R 1184 children, 
median age 6.0 
years  
Each increase in first trimester CRL 
z score was associated with a mean 
reduction in cholesterol of 0.05 
mmol/L [0, 0.10] and of low density 
lipoprotein by mean 0.04 mmol/L 
[0, 0.09]. 
Associations with change in size not 
reported 
Tracking and determinants 
of kidney size from fetal life 
until the age of 2 years: the 
Generation R StudyP19P 
Renal size Generation R 688 two year olds Increased third (but not second) 
trimester HC and AC were positively 
associated with kidney volume at 
two years of age, e.g. each z score 
increase  in HC associated with 
mean increase in renal volume of 
1.3 cmP3P[0.2, 2.4] 
No association between change in fetal 
measurements between second and third 
trimester and renal size. 
Intrauterine growth and 
postnatal skeletal 
development: findings from 
the Southampton Women's 
SurveyP20P 
 
 
 
 
 
Bone mineralisation  
SWS 380 four year olds FL at 19 and 34 weeks positively 
associated with increased bone 
mineral content (BMC, association 
expressed as correlation 
coefficients, 0.13 and 0.31 
respectively).  Associations with AC 
Change in FL between 19 and 34 weeks 
positively associated with increased BMC 
(association expressed as correlation 
coefficient, 0.29) 
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of lesser and sometimes non-
significant magnitude 
Different indices of fetal 
growth predict bone size 
and volumetric density at 4 
years of ageP21P 
SWS 628 four year olds Associations with absolute 
measurements and BMC not 
reported 
Growth in FL and AC between 11PthP and 
19PthP gestational weeks positively 
associated with BMC at birth and at four 
years of age  (regression coefficient 
approximately 0.25-0.35 for all 
comparisons)   
Foetal and postnatal 
growth and bone mass at 6 
months: the Generation R 
StudyP22P 
Generation R 252 six month old 
infants 
EFW at  30 weeks gestation was 
positively associated with total 
body bone mineral density at six 
months of age ( 2% [0.1, 0.3*, 
increase per kg increase in EFW ) 
*as reported in paper, presumed to 
be 3.0 
Increasing EFW between 20 and 30 weeks 
(but not 30 weeks and term) associated 
with total body bone mineral density at six 
months of age (mean increase 0.5% [0.1, 
0.8] per z score increased EFW) 
Fetal and infant growth 
predict hip geometry at 6 y 
old: findings from the 
Southampton Women’s 
Survey P23P  
Hip geometry SWS 493 six year olds Association with size not reported Increasing FL between 19 and 34 weeks 
associated with femoral neck section 
modulus (an index of bending strength) – 
regression coefficient 0.26 cmP3P per z score 
increase. 
SWS=Southampton Women’s Study, FEV1=forced expired volume in one second, CRL=crown rump length, BPD=biparietal diameter, HC=head 
circumference, FL=femur length, AC=abdominal circumference, EFW=estimated fetal weight 
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Table E2.  Quality control.  For each component and the global score, 1=strong, 2=moderate and 3=weak design. 
Study Selection 
Bias 
Study 
Design 
Confounders Blinding Data 
Collection 
Methods 
Withdrawals 
and Drop outs 
Global Rating 
Associations between fetal size, maternal 
alpha-tocopherol and childhood asthma P1P 
2 2 2 1 1 2 1 
First and second trimester fetal size and 
asthma outcomes at age ten years P2P 
2 2 2 1 1 3 2 
Patterns of fetal and infant growth are related 
to atopy and wheezing disorders at age 3 years 
P
3
P 
3 2 2 1 1 2 2 
Fetal and infant growth and asthma symptoms 
in preschool children: the Generation R Study P4P 
3 2 2 1 1 2 2 
Fetal and postnatal growth and body 
composition at 6 months of age P5P 
3 2 3 1 1 2 3 
Growth in foetal life and infancy is associated 
with abdominal adiposity at the age of 2 years: 
the Generation R studyP6P 
3 2 2 1 1 2 2 
Fetal and infant growth and the risk of obesity 
during early childhood: the Generation R 
StudyP7P 
3 2 2 1 1 2 2 
Second trimester estimated fetal weight and 
fetal weight gain predict childhood obesityP9P 
3 2 2 1 1 2 2 
First trimester fetal growth restriction and 
cardiovascular risk factors in school age 
children: population based cohort studyP8P 
3 2 2 1 1 2 2 
Fetal head circumference growth in children 
with specific language impairmentP10P 
3 2 3 1 1 2 3 
Fetal programming of infant neuromotor 
development: the generation R study P11P 
3 2 2 1 1 2 2 
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Fetal growth from mid- to late pregnancy is 
associated with infant development: the 
Generation R StudyP12P 
3 2 2 1 1 2 2 
Brief report: a preliminary study of fetal head 
circumference growth in autism spectrum 
disorderP13P 
3 3 3 1 1 2 3 
A retrospective fetal ultrasound study of brain 
size in autismP14P 
3 3 3 1 1 2 3 
Deviance in fetal growth and risk of autism 
spectrum disorderP15P 
2 2 2 1 1 2 2 
Fetal growth retardation and risk of febrile 
seizuresP16P 
3 2 2 1 1 2 2 
Prenatal ultrasound biometry related to 
subsequent blood pressure in childhoodP17P 
3 2 3 1 1 2 3 
Fetal and postnatal growth and blood pressure 
at the age of 2 years. The Generation R StudyP18P 
3 2 2 1 1 2 2 
Tracking and determinants of kidney size from 
fetal life until the age of 2 years: the 
Generation R StudyP19P 
3 2 3 1 1 2 3 
Intrauterine growth and postnatal skeletal 
development: findings from the Southampton 
Women's SurveyP20P 
3 2 3 1 1 2 3 
Different indices of fetal growth predict bone 
size and volumetric density at 4 years of ageP21P 
3 2 3 1 1 2 3 
Foetal and postnatal growth and bone mass at 
6 months: the Generation R StudyP22P 
3 2 3 1 1 2 3 
Fetal and infant growth predict hip geometry at 6 y 
old: findings from the Southampton Women’s 
Survey P23P  
3 2 3 1 1 2 3 
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Case-control studiesP13-15P were given a weak rating due to study design.  Cohort studies other than SEATON were given a weak rating since evidence on the 
effect of drop outs was not presented.  For selection bias, only the SEATON study presented details of mothers who did and did not participate (moderate 
rating), the remaining studies scored weak rating. The SEATON cohort received a weak rating for withdrawal and drop outs due to a <50% follow up at ten 
yearsP2P.  Blinding was assumed to be strong since the ultrasound measurements were made before postnatal outcomes were known.  Data collection 
methods were all valid.  
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Table E3.  Search terms used and number of results. 
USearch Number # USearches UResults USearch Type 
1 Only Child/ or Child/ or 
Child, Preschool/ or 
Child Development 
1560833 Advanced 
2 Follow-up Studies/ or 
Cohort Studies/ or 
Cross-sectional studies/ 
or Longitudinal studies/ 
or Prospective studies/ 
or Epidemiological 
studies/ 
1001238 Advanced 
3 fetal growth.mp or  
Fetal Development/ 
22848 Advanced 
4 Infant/ or Infant, 
Newborn/ 
936554 Advanced 
 
5 humans/ 13588386 Advanced 
6 1 + 2 + 3 + 4 + 5 450 Advanced 
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